Clinical Trial Update: Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART) [Phase 2]

View source ↗

Summary

Phase 2 trial update on identifying effective doses of SHR7280 tablets to prevent early ovulation in women undergoing controlled ovarian hyperstimulation for as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Controlled Ovarian Hyperstimulation
• Infertility Related to Assisted Reproductive Technology

Drugs mentioned

• SHR7280

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Female Subjects Undergoing COH in ART to Prevent Early Ovulation | Phase 2 | Status: COMPLETED